Case Report: A complicated case of neonatal refeeding syndrome following intrauterine growth restriction corrected by high dose thiamine supplementation

TL;DR

A preterm baby with growth restriction showed rapid recovery from refeeding syndrome after high-dose thiamine treatment.

Contribution

Demonstrates high-dose thiamine's effectiveness in treating refractory refeeding syndrome in IUGR neonates.

Findings

High-dose thiamine normalized severe electrolyte imbalances within 4 hours.

Platelet count improved significantly following thiamine administration.

Standard electrolyte correction failed, but thiamine supplementation resolved refractory RS symptoms.

Abstract

Refeeding syndrome (RS), marked by severe electrolyte imbalances (e.g., hypophosphatemia, hypokalemia) and thiamine deficiency, poses significant risks during nutritional rehabilitation in intrauterine growth restriction (IUGR) neonates. This case report highlights the efficacy of high-dose thiamine (2 mg/kg IV) in resolving refractory RS in a preterm IUGR infant (34 weeks, 1,415 g) unresponsive to standard electrolyte correction. Despite gradual caloric reintroduction and parenteral supplementation, the infant exhibited persistent hypophosphatemia (3.0 mmol/kg/day IV requirement), hypokalemia (4.3 mmol/kg/day IV requirement), and thrombocytopenia (nadir 27 × 109/L). Thiamine administration led to rapid clinical improvement within 4 h, with electrolyte normalization (potassium: 2.19→4.41 mmol/L; phosphorus: 0.69 →2.35 mmol/L) and platelet recovery (27→112 × 109/L). The findings suggest thiamine deficiency may underlie refractory RS in IUGR neonates, advocating for early supplementation in high-risk cases. Further research is needed to optimize dosing and validate thiamine's role in RS management.

Figures